Cargando…
IER3 (IEX‐1) dysregulation serves as a potential prognostic factor in acute myeloid leukemia patients
INTRODUCTION: Immediate early response 3 (IER3) has association with hematological malignancies’ risk and prognosis, such as myelodysplastic syndrome, while its relation to acute myeloid leukemia (AML) is not clear. This study aimed to explore the correlation of IER3 with AML risk, clinical characte...
Autores principales: | Ke, Shandong, Zhang, Xin, Xiang, Xiuzhi, Lu, Yalan, An, Hongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298238/ https://www.ncbi.nlm.nih.gov/pubmed/34729939 http://dx.doi.org/10.1111/ijlh.13749 |
Ejemplares similares
-
François Ier /
por: Castelot, André
Publicado: (1983) -
Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia
por: Zhou, Jing-dong, et al.
Publicado: (2018) -
Dipetidyl peptidase-4 and transferrin receptor serve as prognostic biomarkers for acute myeloid leukemia
por: Wei, Jie, et al.
Publicado: (2021) -
Dysregulated IER3 Expression is Associated with Enhanced Apoptosis in Titin-Based Dilated Cardiomyopathy
por: Zhou, Qifeng, et al.
Publicado: (2017) -
IER3 in pancreatic carcinogenesis
por: Molejon, Maria Inés, et al.
Publicado: (2015)